Propanc Biopharma, Inc. (PPCB): debt financing — Propanc Biopharma issues $60,000 promissory note to accredited investor

Propanc Biopharma, Inc.

Principal amount $60,000; purchase price $50,000 (implicit $10,000 discount).
Maturity July 15, 2025; interest at 10% per annum.
Repayment at 100% of principal if on/before July 7, 2025; 120% if after through Aug 7, 2025.
Proceeds for general working capital; note issued under Section 4(a)(2) private placement.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Propanc Biopharma, Inc. incurred loan of $60,000 with an accredited investor at ten percent (10%) per annum maturing July 15, 2025.

Instrument: loan
Principal: $60,000
Counterparty: an accredited investor
Rate: ten percent (10%) per annum
Maturity: July 15, 2025
Event: incurrence

Exact text from the filing

Effective June 2, 2025, Propanc Biopharma, Inc. (the “Company”) issued a Promissory Note to an accredited investor (the “Investor”) in the aggregate principal amount of $60,000 (the “Note”), for a purchase price of $50,000.

View on SEC.gov

10 debt financings filed in the last 30 days. Browse all debt financings →

Propanc Biopharma, Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-013285

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.